Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

CNBC

Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight

EconomyDaily Composite
ShareXFacebook

Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity injection Wegovy.

C

Source

CNBC

Read full article at CNBC

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement